Diabeloop won CE Mark clearance in the European Union this month for its hybrid closed-loop diabetes management system, DBLG1.
The Paris-based company hopes to launch its “artificial pancreas” system for adults with Type I diabetes in Europe by the second quarter in 2019.
Get the full story at our sister site, Drug Delivery Business News.
The post Diabeloop wins CE Mark for hybrid closed-loop diabetes management system appeared first on MassDevice.